Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry

Autism spectrum disorders (ASDs) are neurobehavioral disorders characterized by abnormalities in three behavioral domains including social interaction, impaired communication, and repetitive stereotypic behaviors. ASD affects approximately 1% of children and is on the rise with significant genetic m...

Full description

Bibliographic Details
Main Authors: Merlin G. Butler, Erin L. Youngs, Jennifer L. Roberts, Jessica A. Hellings
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Autism Research and Treatment
Online Access:http://dx.doi.org/10.1155/2012/242537
id doaj-f3ad868f51e6455bb186ccd3f63c7eff
record_format Article
spelling doaj-f3ad868f51e6455bb186ccd3f63c7eff2020-11-24T20:40:39ZengHindawi LimitedAutism Research and Treatment2090-19252090-19332012-01-01201210.1155/2012/242537242537Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and PsychiatryMerlin G. Butler0Erin L. Youngs1Jennifer L. Roberts2Jessica A. Hellings3Department of Psychiatry and Behavioral Sciences, Kansas University Medical Center, 3901 Rainbow Blvd., MS4015, Kansas City, KS 66160, USASaint Luke’s Cancer Institute, Saint Luke’s Health System, Kansas City, MO 64111, USADepartment of Psychiatry and Behavioral Sciences, Kansas University Medical Center, 3901 Rainbow Blvd., MS4015, Kansas City, KS 66160, USADepartment of Psychiatry and Behavioral Sciences, Kansas University Medical Center, 3901 Rainbow Blvd., MS4015, Kansas City, KS 66160, USAAutism spectrum disorders (ASDs) are neurobehavioral disorders characterized by abnormalities in three behavioral domains including social interaction, impaired communication, and repetitive stereotypic behaviors. ASD affects approximately 1% of children and is on the rise with significant genetic mechanisms underlying these disorders. We review the current understanding of the role of genetic and metabolic factors contributing to ASD with the use of new genetic technology. Fifty percent is diagnosed with chromosomal abnormalities, small DNA deletions/duplications, single-gene conditions, or metabolic disturbances. Genetic evaluation is discussed along with psychiatric treatment and approaches for selection of medication to treat associated challenging behaviors or comorbidities seen in ASD. We emphasize the importance of prioritizing treatment based on target symptom clusters and in what order for individuals with ASD, as the treatment may vary from patient to patient.http://dx.doi.org/10.1155/2012/242537
collection DOAJ
language English
format Article
sources DOAJ
author Merlin G. Butler
Erin L. Youngs
Jennifer L. Roberts
Jessica A. Hellings
spellingShingle Merlin G. Butler
Erin L. Youngs
Jennifer L. Roberts
Jessica A. Hellings
Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry
Autism Research and Treatment
author_facet Merlin G. Butler
Erin L. Youngs
Jennifer L. Roberts
Jessica A. Hellings
author_sort Merlin G. Butler
title Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry
title_short Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry
title_full Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry
title_fullStr Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry
title_full_unstemmed Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry
title_sort assessment and treatment in autism spectrum disorders: a focus on genetics and psychiatry
publisher Hindawi Limited
series Autism Research and Treatment
issn 2090-1925
2090-1933
publishDate 2012-01-01
description Autism spectrum disorders (ASDs) are neurobehavioral disorders characterized by abnormalities in three behavioral domains including social interaction, impaired communication, and repetitive stereotypic behaviors. ASD affects approximately 1% of children and is on the rise with significant genetic mechanisms underlying these disorders. We review the current understanding of the role of genetic and metabolic factors contributing to ASD with the use of new genetic technology. Fifty percent is diagnosed with chromosomal abnormalities, small DNA deletions/duplications, single-gene conditions, or metabolic disturbances. Genetic evaluation is discussed along with psychiatric treatment and approaches for selection of medication to treat associated challenging behaviors or comorbidities seen in ASD. We emphasize the importance of prioritizing treatment based on target symptom clusters and in what order for individuals with ASD, as the treatment may vary from patient to patient.
url http://dx.doi.org/10.1155/2012/242537
work_keys_str_mv AT merlingbutler assessmentandtreatmentinautismspectrumdisordersafocusongeneticsandpsychiatry
AT erinlyoungs assessmentandtreatmentinautismspectrumdisordersafocusongeneticsandpsychiatry
AT jenniferlroberts assessmentandtreatmentinautismspectrumdisordersafocusongeneticsandpsychiatry
AT jessicaahellings assessmentandtreatmentinautismspectrumdisordersafocusongeneticsandpsychiatry
_version_ 1716826114757754880